Multicenter trial
A multicenter research trial is a clinical trial that involves more than one independent medical institutions in enrolling and following trial participants.[1] In multicenter trials the participant institutions follow a common treatment protocol and follow the same data collection guidelines, and there is a single coordinating center that receives, processes and analyzes study data.[2][3]
Benefits
An important benefit of multicenter trials is that they permit the enrollment of a larger number of participants at a faster rate, in comparison to a single-center trial, putting to use the sources of multiple institutions.
The benefits of multicenter trials also include the potential for a more heterogenous sample of participants, from different geographic locations and a wider range of population groups, treated from physicians of different backgrounds, and the ability to compare results among centers, all of which increase the generalizability of the study. In many cases, efficacy will vary significantly between population groups with different genetic, environmental, and ethnic or cultural backgrounds ("demographic" factors); multicenter trials are better at evaluating these factors, by giving the opportunity for more subgroup analyses. Heterogeneity in the sample means that the findings will be more generalizable.[4] On the other hand, a more heterogeneous study population generally requires a larger sample size to detect a given difference. [2]
References
- ISBN 9783319185392. Retrieved 12 February 2024.
- ^ ISBN 9780199864478. Retrieved 12 February 2024.
- ISBN 9781118445112. Retrieved 12 February 2024.
- ^ a b Bryant 2014, p. 3.